QuidelOrtho Corporation (QDEL)

Market Cap	3.02B
Revenue (ttm)	2.82B
Net Income (ttm)	-1.87B
Shares Out	67.26M
EPS (ttm)	-27.85
PE Ratio	n/a
Forward PE	21.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,564,287
Open	42.86
Previous Close	43.03
Day's Range	42.69 - 45.98
52-Week Range	29.74 - 75.86
Beta	0.10
Analysts	Buy
Price Target	53.43 (+19.16%)
Earnings Date	Feb 11, 2025

About QDEL

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 7,100
• Stock Exchange: NASDAQ
• Ticker Symbol: QDEL
• Website: https://www.quidelortho.com

Analyst Forecast

According to 8 analysts, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is $53.43, which is an increase of 19.16% from the latest price.

Price Target

$53.43

(19.16% upside)

Analyst Consensus: Buy